![Someit Sidhu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Someit Sidhu
Algemeen Directeur bij
Izana Bioscience Ltd.
Vermogen: 22 M $ op 31-07-2026
Profiel
Someit Sidhu is the founder of Izana Bioscience Ltd., founded in 2017, holding the title of Chief Executive Officer.
Dr. Sidhu was the founder of Pathios Therapeutics Ltd., founded in 2017, holding the title of Chief Business Officer from 2017 to 2019.
Dr. Sidhu is the founder of JATT Acquisition Corp., founded in 2021, holding the title of Chief Executive Officer & Director.
Dr. Sidhu is the founder of Akaza Bioscience Ltd., founded in 2019, holding the title of Chief Executive Officer.
Dr. Sidhu was the founder of Zura Bio Ltd., founded in 2022, holding the title of Non-Independent Director from 2024 to 2026.
Dr. Sidhu is also the founder of Khanda Therapeutics LP..
Dr. Sidhu currently holds the positions of Chairman & Chief Executive Officer at JATT II Acquisition Corp., Chairman & Chief Executive Officer at JATT Ventures LP, Chief Executive Officer at Zenios Bioscience LLP, and Chairman & Chief Executive Officer at JATT III Acquisition Corp.
Dr. Sidhu completed undergraduate education at Oxford University Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-04-2026 | 3.994.290 ( 4,2% ) | 22 M $ | 31-07-2026 |
Actieve functies van Someit Sidhu
| Bedrijven | Functie | Begin |
|---|---|---|
Izana Bioscience Ltd.
 Izana Bioscience Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology activities | Algemeen Directeur | 26-05-2017 |
Akaza Bioscience Ltd. | Algemeen Directeur | 01-01-2019 |
Zenios Bioscience LLP | Algemeen Directeur | - |
JATT Ventures LP | Algemeen Directeur | - |
Eerdere bekende functies van Someit Sidhu
| Bedrijven | Functie | Einde |
|---|---|---|
| ZURA BIO LIMITED | Oprichter | 21-05-2026 |
Pathios Therapeutics Ltd.
 Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Oprichter | 28-08-2019 |
| JATT ACQUISITION CORP | Algemeen Directeur | - |
Opleiding van Someit Sidhu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
37
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Oxford University Medical School
 Oxford University Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Izana Bioscience Ltd.
Izana Bioscience Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology activities | Health Technology |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Health Technology |
JATT Acquisition Corp.
 JATT Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
JATT Ventures LP | |
Akaza Bioscience Ltd. | |
Zenios Bioscience LLP | |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
